4,419 results on '"Schreiber, Stefan"'
Search Results
2. Die Assumptio Mosis. Studien zur Rezeption massgültiger Überlieferung (review)
3. Epidemiologische Daten und medizinische Versorgungssituation von Patienten mit chronischen Entzündungserkrankungen in Deutschland: Real-World-Evidenz zu Prävalenz, Erkrankungskombinationen, Versorgung
4. Amino acid auxotrophies in human gut bacteria are linked to higher microbiome diversity and long-term stability
5. Persistent symptoms and risk factors predicting prolonged time to symptom-free after SARS‑CoV‑2 infection: an analysis of the baseline examination of the German COVIDOM/NAPKON-POP cohort
6. Trends in the epidemiology of Clostridioides difficile infection in Germany
7. Selection of cross-reactive T cells by commensal and food-derived yeasts drives cytotoxic TH1 cell responses in Crohn’s disease
8. Switching from intravenous to subcutaneous infliximab maintenance therapy in inflammatory bowel disease: Post hoc longitudinal analysis of a randomized trial
9. Genome-wide association analysis reveals the associations of NPHP4, TYW1-AUTS2 and SEMA6D for Behçet's disease and HLA-B*46:01 for its intestinal involvement
10. Mirikizumab bei Colitis ulcerosa
11. Depression and fatigue six months post-COVID-19 disease are associated with overlapping symptom constellations: A prospective, multi-center, population-based cohort study
12. Effects of lifestyle and associated diseases on serum CC16 suggest complex interactions among metabolism, heart and lungs
13. Tryptophan degradation as a systems phenomenon in inflammation – an analysis across 13 chronic inflammatory diseases
14. Serine metabolism is crucial for cGAS-STING signaling and viral defense control in the gut
15. Predictors of non-recovery from fatigue and cognitive deficits after COVID-19: a prospective, longitudinal, population-based study
16. Subcutaneous Infliximab Monotherapy Versus Combination Therapy with Immunosuppressants in Inflammatory Bowel Disease: A Post Hoc Analysis of a Randomised Clinical Trial
17. Subcutaneous Infliximab (CT-P13 SC) as Maintenance Therapy for Inflammatory Bowel Disease: Two Randomized Phase 3 Trials (LIBERTY)
18. Upadacitinib Achieves Clinical and Endoscopic Outcomes in Crohn’s Disease Regardless of Prior Biologic Exposure
19. Transethnic analysis of the human leukocyte antigen region for ulcerative colitis reveals not only shared but also ethnicity-specific disease associations.
20. Dynamic changes in extracellular vesicle-associated miRNAs elicited by ultrasound in inflammatory bowel disease patients
21. FixNCut: single-cell genomics through reversible tissue fixation and dissociation
22. HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44+ Natural Killer Cells in Ulcerative Colitis
23. THU-254-YI Differential gene expression profiles of liver tissue, subcutaneous and visceral adipose tissue delineates severity of MASLD in heavily obese patients
24. Upadacitinib Therapy Reduces Ulcerative Colitis Symptoms as Early as Day 1 of Induction Treatment
25. Cohort profile: the Food Chain Plus (FoCus) cohort
26. Atmungstherapie an einem Universitätsklinikum: eine Evaluation des Tätigkeitsprofils
27. Large-scale sequencing identifies multiple genes and rare variants associated with Crohn’s disease susceptibility
28. Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies
29. Resilienz als Resonanzfähigkeit. Ein affekttheoretischer Blick auf ein psycho-sozio-archäologisches Forschungsfeld
30. The German National Pandemic Cohort Network (NAPKON): rationale, study design and baseline characteristics
31. Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era
32. NF-κB/RelA controlled A20 limits TRAIL-induced apoptosis in pancreatic cancer
33. AMISELIMOD FOR THE TREATMENT OF ACTIVE ULCERATIVE COLITIS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
34. Safety, tolerability, and pharmacokinetics of single‐ and multiple‐ascending doses of olamkicept: Results from randomized, placebo‐controlled, first‐in‐human phase I trials
35. Manifestation of an immunologic dysbalance in the otological and sinunasal area based on therapeutic damage in autoimmune diseases
36. Single-cell RNA sequencing of nasal mucosa for molecular and genetic analysis of chemosensory dysfunction in post-COVID patients
37. Efficacy and Safety of Etrasimod in Patients with Moderately to Severely Active Isolated Proctitis: Results From the Phase 3 ELEVATE UC Clinical Programme
38. Changes of Periodontal Parameters and Microbiome Composition of Tooth Pocket in Patients with Chronic Inflammatory Diseases Receiving Targeted Anti-Cytokine Therapy
39. Correspondence
40. Dynamic Changes in Extracellular Vesicle-Associated miRNAs Elicited by Ultrasound in Inflammatory Bowel Disease Patients
41. Contrast-Enhanced Endoscopic Ultrasound Detects Early Therapy Response Following Anti-TNF Therapy in Patients with Ulcerative Colitis
42. Inflammatory bowel disease (IBD) patients with impaired quality of life on biologic therapy benefit from the support of an IBD nurse specialist: Results of a randomised controlled trial in Germany (IBDBIO‐ASSIST study)
43. Longitudinal multi-omics analysis identifies early blood-based predictors of anti-TNF therapy response in inflammatory bowel disease
44. Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity
45. DNA methyltransferase 3A controls intestinal epithelial barrier function and regeneration in the colon
46. Statistical biases due to anonymization evaluated in an open clinical dataset from COVID-19 patients
47. Cross-tissue transcriptome-wide association studies identify susceptibility genes shared between schizophrenia and inflammatory bowel disease
48. Fatigue and cognitive impairment after COVID-19: A prospective multicentre study
49. Ozanimod as a novel oral small molecule therapy for the treatment of Crohn's disease: The YELLOWSTONE clinical trial program
50. IOIBD Recommendations for Clinical Trials in Ulcerative Proctitis: The PROCTRIAL Consensus
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.